Day: July 25, 2021

Wogonin inhibits cardiac hypertrophy by activating Nrf-2-mediated antioxidant responses.

Wogonin inhibits cardiac hypertrophy by activating Nrf-2-mediated antioxidant responses.

PMID:  Cardiovasc Ther. 2021 ;2021:9995342. Epub 2021 Jul 1. PMID: 34290825 Abstract Title:  Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses. Abstract:  Background: Cardiac hypertrophy is one of the initial disorders of the cardiovascular system and can induce heart failure. Oxidative stress is an important pathophysiological mechanism of cardiac hypertrophy. Wogonin (Wog), an important…

Close
Menu